Drawing for HEALX

USPTO serial 79279054

HEALX

Reviewed by CopyMark Law Group

Reg. 6375040Status 700Renewal
Filing date
Status date
Registration date
Jun 8, 2021
Examiner
BLANE, SUZANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEALX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jesse A. Hirshman

Jesse A. Hirshman The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical drugs; drugs for medical purposes; medicines for human purposes; all of the goods for use in treating rare diseasesACTIVE—
042Scientific and technological services and research and design relating thereto, namely, drug discovery services using artificial intelligence; industrial analysis and research services; design and development of computer hardware and software; biological research; research and development of new products for others; pharmaceutical drug development services; drug discovery services; data and literature mining services, namely, the development of automated Natural Language Processing software; software design; computer software design; consultancy pertaining to pharmacology; consultancy pertaining to pharmaceuticals; maintaining databases pertaining to rare diseases; medical treatment for rare diseases; scientific research for medical purposes in the field of rare diseases; research and development services in the field of artificial intelligence; computer software development; computer software development for use in the healthcare field; computer software development for use in the field of rare diseases; design and development of computer software for use in the healthcare field; design and development of computer software for use in the field of rare diseasesACTIVE—
044Medical services; health consultancy; healthcare services; medical treatment services for rare diseases; healthcare advisory services; collation of information in the healthcare sector, namely, the development and collation of rare disease knowledge data sets; pharmaceutical advice; medical clinic services; medical advice for individuals with rare diseases; advisory services relating to rare diseases; advisory services relating to treatment of rare diseases; provision of medicine in the field of rare diseases, namely, developing treatments for unmet medical needsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 24, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 29, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 29, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 8, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 23, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 23, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 3, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 3, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 3, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2021ALIEASSIGNED TO LIE—
Oct 9, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 14, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 1, 2020RFNTREFUSAL PROCESSED BY IB—
Apr 16, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 16, 2020RFRRREFUSAL PROCESSED BY MPU—
Apr 1, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 31, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2020DOCKASSIGNED TO EXAMINER—
Feb 28, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 24, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 20, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance